Phase II trial of 6-diazo-5-oxo-L-norleucine versus aclacinomycin-A in advanced sarcomas and mesotheliomas. [electronic resource]
Producer: 19900629Description: 113-9 p. digitalISSN:- 0167-6997
- Aclarubicin -- adverse effects
- Azo Compounds -- therapeutic use
- Bone Neoplasms -- drug therapy
- Diazooxonorleucine -- adverse effects
- Drug Administration Schedule
- Drug Evaluation
- Female
- Humans
- Infusions, Intravenous
- Male
- Mesothelioma -- drug therapy
- Middle Aged
- Randomized Controlled Trials as Topic
- Sarcoma -- drug therapy
- Soft Tissue Neoplasms -- drug therapy
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.